Delcath Systems to Host Third Quarter 2026 Earnings Call
Business Wire•26/10/2026•08:30 ET
0
Key Highlights
- ➤Delcath schedules Q3 2026 earnings call for November 9, 2026
- ➤Call will discuss results for quarter ended September 30, 2026
- ➤HEPZATO KIT approved for eligible metastatic uveal melanoma liver metastases
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on November 9, 2026, at 8:30 AM Eastern Time to discuss results for its third quarter ended September 30, 2026.
To participate in this event, dial in approximately 5 to 10 minutes before the beginning of the call.
Get started
Create a free account to read the full story.